DUBLIN — April 2, 2020 — Horizon Therapeutics plc (Nasdaq: HZNP) announced today that it has acquired Curzion Pharmaceuticals, Inc., a privately held development-stage biopharma company, and its development-stage oral...
Mike Grey will speak on “What Are the Funding Sources and How to Apply” at the American Chemical Society meeting in San Diego, CA
News | 10. 09. 2010
